Drug Trial Radar · NCT00024167
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Mar 22, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
265
Actual
Start
Apr 2002
Primary completion
Sep 2014
Sponsor
- Lead sponsor
- M.D. Anderson Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radioactive substances such as strontium-89 may relieve bone pain associated with prostate cancer. It is not yet known whether chemotherapy is more effective with or without strontium-89 in treating bone metastases. PURPOSE: This randomized phase III trial is studying giving chemotherapy together with strontium-89 to see how well it works compared to chemotherapy alone in treating patients with prostate cancer that has spread to the bone.
Conditions
- Prostate Cancer
Interventions
DocetaxelDrug
75 mg/m2 intravenous piggyback (IVPB) over 1 hour, Day 1, every 3 weeks.
Doxorubicin hydrochlorideDrug
20 mg/m2 IV, day 1 on Weeks 1, 3, 5
Estramustine phosphate sodiumDrug
140 mg orally 3 x day, Days 1 through 7 on Weeks 2, 4, 6
KetoconazoleDrug
400 mg orally (po) 3 x day, Days 1 through 7
PrednisoneDrug
5 mg orally 2 x daily, weeks 1-14
VinblastineDrug
4 mg/m2 IVPB, Day 1 on Weeks 2, 4, 6
Strontium chloride Sr 89Radiation
One dose (4 mCi total dose) IV
DexamethasoneDrug
4 mg is given orally at 12 and 1 hours before and 12 hours after docetaxel.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival From RandomizationTime frame: Followed every 4 weeks from randomization until death, up to 7 years.
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Northeast Georgia Medical Center
Gainesville, Georgia
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia
Veterans Affairs Medical Center - Hines
Hines, Illinois
Swedish-American Regional Cancer Center
Rockford, Illinois
Hematology Oncology Associates of the Quad Cities
Bettendorf, Iowa
Genesis Regional Cancer Center at Genesis Medical Center
Davenport, Iowa
Siouxland Hematology-Oncology Associates, LLP
Sioux City, Iowa
Mercy Medical Center - Sioux City
Sioux City, Iowa
St. Luke's Regional Medical Center
Sioux City, Iowa
University of Mississippi Cancer Clinic
Jackson, Mississippi
CCOP - Montana Cancer Consortium
Billings, Montana
Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana
Northern Rockies Radiation Oncology Center
Billings, Montana
St. Vincent Healthcare Cancer Care Services
Billings, Montana
Billings Clinic - Downtown
Billings, Montana
Bozeman Deaconess Cancer Center
Bozeman, Montana
St. James Healthcare Cancer Care
Butte, Montana
Big Sky Oncology
Great Falls, Montana
Great Falls Clinic - Main Facility
Great Falls, Montana
Sletten Cancer Institute at Benefis Healthcare
Great Falls, Montana
Site not named
Great Falls, Montana
St. Peter's Hospital
Helena, Montana
Glacier Oncology, PLLC
Kalispell, Montana
Kalispell Medical Oncology at KRMC
Kalispell, Montana
Kalispell Regional Medical Center
Kalispell, Montana
Community Medical Center
Missoula, Montana
Guardian Oncology and Center for Wellness
Missoula, Montana
Montana Cancer Specialists at Montana Cancer Center
Missoula, Montana
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Missoula, Montana
Good Samaritan Cancer Center at Good Samaritan Hospital
Kearney, Nebraska
Kinston Medical Specialists
Kinston, North Carolina
Summa Center for Cancer Care at Akron City Hospital
Akron, Ohio
Barberton Citizens Hospital
Barberton, Ohio
Cancer Care Center, Incorporated
Salem, Ohio
Cancer Treatment Center
Wooster, Ohio
McLeod Regional Medical Center
Florence, South Carolina
CCOP - Greenville
Greenville, South Carolina
Medical City Dallas Hospital
Dallas, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas
Welch Cancer Center at Sheridan Memorial Hospital
Sheridan, Wyoming
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.